Copyright
©The Author(s) 2018.
World J Gastrointest Oncol. Jan 15, 2018; 10(1): 31-39
Published online Jan 15, 2018. doi: 10.4251/wjgo.v10.i1.31
Published online Jan 15, 2018. doi: 10.4251/wjgo.v10.i1.31
Table 4 Overall survival of patients with T4bN1-3M0/TxN3bM0 gastric cancer according to distant site of metastasis
| Distant metastasis site | Recurrent patients (n = 147) | Median OS (mo) | 5-yr OS(%) | |
| n | % | |||
| Liver | 26 | 17.7% | 18.3 | 15.5% |
| Lung and pleura | 12 | 8.2% | 16.8 | 0.0% |
| Bone | 10 | 6.8% | 30.7 | 29.2% |
- Citation: Wang QW, Zhang XT, Lu M, Shen L. Impact of duration of adjuvant chemotherapy in radically resected patients with T4bN1-3M0/TxN3bM0 gastric cancer. World J Gastrointest Oncol 2018; 10(1): 31-39
- URL: https://www.wjgnet.com/1948-5204/full/v10/i1/31.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v10.i1.31